Vaccine development for COVID-19 is topic number one, and our collective hope for going back to “normal” dangle on that needle. The global race to market includes pharma’s heavy hitters like Pfizer, Johnson & Johnson, AstraZeneca, and Moderna, a Cambridge, Massachusetts-based company that displayed hopeful results in Phase-1 trials and just this week received another… Read more about COVID-19 Update: The Race for a Vaccine
As the US topped a whopping 2.8 million cases and a death count of 130,000 last week, cities and towns across the nation canceled July 4th firework displays and large public gatherings in an effort to prevent further spread of COVID-19. The fervor for holiday travel was scaled down this past weekend compared to prior… Read more about COVID-19 Update: The Disparity Between the US and the EU COVID-19 Experience
When movies are made about the COVID-19 pandemic, the city of New York will have a starring role. Once the epicenter of the virus outbreak, the densely populated city endured months of significantly high rates of confirmed infections and reported deaths. As cases began to steadily decrease in the month of May, Governor Cuomo’s daily… Read more about COVID-19 Update: What is the New Normal for Businesses?
Improved data collection and relaxed social distancing will likely lead to an increase in both the perceived and actual spread of COVID-19 Part I: The Numbers Since the beginning of the COVID-19 outbreak, data has been scrutinized for accuracy. Are officials capable of reporting correct numbers? How do we reconcile the lack of resources to… Read more about Why COVID-19 Infections May Resurge
This page will be updated twice daily to include the latest numbers and developments surrounding COVID-19 Overview: The United States is experiencing sustained human-to-human transmission of the novel COVID-19 virus, first discovered in Wuhan, China in December 2019. Since then, every state in the US has confirmed cases, and new cases are emerging every day.… Read more about COVID-19 FACT SHEET WITH PHYSICIAN-RECOMMENDED PREVENTATIVE MEASURES
Serological testing, also known as antibody testing, is a critical element of discussion when determining how and when the country will reopen. The process requires a blood sample to detect the presence of neutralizing antibodies (IgM, IgG) against a microorganism. Serological antibody tests are unlike polymerase chain reaction (PCR) diagnostic tests as the latter specifically… Read more about Coronavirus Update: Serological Testing
Reopening the Country Just 6 weeks ago, the US had 100 confirmed cases of COVID-19 and 6 deaths – all in Washington state. Today, the country is a vastly different place. There are 560,433+ confirmed cases in all 50 states and in all US-held territories, and 22,115+ COVID-19 related deaths and the US leads the… Read more about Coronavirus Update: Reopening the Country
COVID-19 Modeling & Projections One of the only constants of the COVID-19 pandemic is how often data and projections are changing. This is frustrating for our society, as there is a collective overwhelming desire to know when the US will hit its peak of cases, and when life can resume normalcy, and those timelines seem… Read more about Coronavirus Update: COVID-19 Modeling & General-Use Face Masks
On February 29, less than one month ago, the US reported 16 cases of COVID-19. Today, the US has the third-highest number of cases in the world (behind China and Italy) topping 46,548 cases and at least 600 deaths, reflecting mass community spread and an uptick in testing capacities across the states. As daunting as… Read more about Coronavirus Update: COVID-19 Testing in the United States
American life as we know it has changed drastically over the past week, and today President Trump asked all Americans to work from home if they can and to avoid gatherings of more than 10 people. The NBA, NHL and PGA, college basketball and other US sports have all suspended play. Nearly 20 states have… Read more about Coronavirus Update: Trump: Americans Should Work from Home/Case Fatality Rates, Flu vs COVID-19
